Skip to main content
. 2021 Sep 4;13(17):4456. doi: 10.3390/cancers13174456
AI artificial intelligence
AOIs areas of illumination
CNBs core needle biopsies
CT tumor center
CTA Cancer Transcriptome Atlas
DCIS ductal carcinoma in situ
DFS disease free survival
DSP Digital Spatial Profiler
ECM extracellular matrix
ER estrogen receptor
FFPE formalin-fixed paraffin-embedded
GBCC GeoMx Breast Cancer Consortium
GSEA gene set enrichment analysis
H&E hematoxylin and eosin
HCA Human Cell Atlas
HER2 epidermal growth factor receptor 2
HK housekeeping
HuBMAP Human Biomolecular Atlas Program
IDC invasive ductal carcinoma
IgG immunoglobulin G
IHC immunohistochemistry
ILC invasive lobular carcinoma
IM invasive margin
LCIS lobular carcinoma in situ
MIAME Minimum Information About a Microarray Experiment
MINSEQE Minimum Information About a Next-generation Sequencing Experiment
NGS next generation sequencing
PanCK pan-cytokeratin
PCA principal component analysis
pCR pathological complete response
PD pharmacodynamic
PR progesterone receptor
ROIs regions of interest
TILs tumor-infiltrating lymphocytes
TMA tissue microarray
TME tumor microenvironment
TMM trimmed mean of M values
TNBC triple-negative breast cancer
tSNE t-distributed stochastic neighbor embedding
UMAP uniform manifold approximation and projection
UV ultraviolet
WTA Whole Transcriptome Atlas